Tarceva 150 mg Tablet
  1. Home
  2. Pharma Products
  3. Roche Products India Pvt Ltd
  4. Tarceva 150 mg Tablet

Tarceva 150 mg Tablet

Tarceva 150 mg Tablet contains erlotinib 150 mg, an oral targeted anticancer medicine. It is used in the treatment of non-small cell lung cancer and pancreatic cancer. The tablet is taken orally on an empty stomach as prescribed by a healthcare professional.

BUY NOW

Category

Erlotinib is a tyrosine kinase inhibitor that blocks epidermal growth factor receptor signaling involved in cancer-cell growth. Tarceva is used in specific treatment settings for non-small cell lung cancer and pancreatic cancer. Each tablet contains 150 mg of erlotinib, and the product is marketed in India by Roche Products India Pvt Ltd. It should be stored below 30°C and taken at least 1 hour before or 2 hours after food.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 150 mg
Dosage Form Tablet
Route of Administration Oral
Therapeutic Class Tyrosine Kinase Inhibitor
Storage Below 30°C

Product Also Known As

Tarceva 150 mg Tablet, Tarceva 150 Tablet, Tarceva Erlotinib Tablet, Tarceva 150 mg, Erlotinib 150 mg Tablet, Erlotinib 150 mg, Erlotinib Tablet